PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1986 April; 79(4): 226–229.
PMCID: PMC1290280

Infections caused by opportunist mycobacteria: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (810K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Collins CH, Grange JM, Yates MD. Mycobacteria in water. J Appl Bacteriol. 1984 Oct;57(2):193–211. [PubMed]
  • LINELL F, NORDEN A. Mycobacterium balnei, a new acid-fast bacillus occurring in swimming pools and capable of producing skin lesions in humans. Acta Tuberc Scand Suppl. 1954;33:1–84. [PubMed]
  • TIMPE A, RUNYON EH. The relationship of atypical acid-fast bacteria to human disease; a preliminary report. J Lab Clin Med. 1954 Aug;44(2):202–209. [PubMed]
  • Collins CH, Grange JM, Noble WC, Yates MD. Mycobacterium marinum infections in man. J Hyg (Lond) 1985 Apr;94(2):135–149. [PMC free article] [PubMed]
  • Jackson PG, Keen H, Noble CJ, Simmons NA. Injection abscesses due to mycobacterium chelonei occurring in a diabetic patient. Tubercle. 1981 Dec;62(4):277–279. [PubMed]
  • Borghans JG, Stanford JL. Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis. 1973 Jan;107(1):1–8. [PubMed]
  • Kuritsky JN, Bullen MG, Broome CV, Silcox VA, Good RC, Wallace RJ., Jr Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med. 1983 Jun;98(6):938–939. [PubMed]
  • Gangadharam PR, Lanier JD, Jones DE. Keratitis due to Mycobacterium chelonei. Tubercle. 1978 Mar;59(1):55–60. [PubMed]
  • Moulsdale MT, Harper JM, Thatcher GN, Dunn BL. Infection by Mycobacterium haemophilum, a metabolically fastidious acid-fast bacillus. Tubercle. 1983 Mar;64(1):29–36. [PubMed]
  • Grange J, Collins C, Yates M. Bacteriological survey of tuberculous lymphadenitis in South-east England: 1973-80. J Epidemiol Community Health. 1982 Sep;36(3):157–161. [PMC free article] [PubMed]
  • Jenkins PA. Mycobacterium malmoense. Tubercle. 1985 Sep;66(3):193–195. [PubMed]
  • Cohen RJ, Samoszuk MK, Busch D, Lagios M. Occult infections with M. intracellulare in bone-marrow biopsy specimens from patients with AIDS. N Engl J Med. 1983 Jun 16;308(24):1475–1476. [PubMed]
  • Graybill JR, Silva J, Jr, Fraser DW, Lordon R, Rogers E. Disseminated mycobacteriosis due to Mycobacterium abcessus in two recipients of renal homografts. Am Rev Respir Dis. 1974 Jan;109(1):4–10. [PubMed]
  • Leff DR, Leff AR. Current treatment modes for tuberculosis. Public policy and implementation. Chest. 1985 Feb;87(2):139–140. [PubMed]
  • Azadian BS, Beck A, Curtis JR, Cherrington LE, Gower PE, Phillips M, Eastwood JB, Nicholls J. Disseminated infection with mycobacterium chelonei in a haemodialysis patient. Tubercle. 1981 Dec;62(4):281–284. [PubMed]
  • Weinstein RA, Stamm WE, Anderson RL. Early detection of false-positive acid-fast smears. An epidemiological approach. Lancet. 1975 Jul 26;2(7926):173–174. [PubMed]
  • Bass JB, Jr, Hawkins EL. Treatment of disease caused by nontuberculous mycobacteria. Arch Intern Med. 1983 Jul;143(7):1439–1441. [PubMed]
  • Moran JF, Alexander LG, Staub EW, Young WG, Jr, Sealy WC. Long-term results of pulmonary resection for atypical mycobacterial disease. Ann Thorac Surg. 1983 Jun;35(6):597–604. [PubMed]
  • Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. Thorax. 1983 Apr;38(4):271–274. [PMC free article] [PubMed]
  • Smith MJ, Citron KM. Clinical review of pulmonary disease caused by Mycobacterium xenopi. Thorax. 1983 May;38(5):373–377. [PMC free article] [PubMed]
  • Banks J, Jenkins PA, Smith AP. Pulmonary infection with Mycobacterium malmoense--a review of treatment and response. Tubercle. 1985 Sep;66(3):197–203. [PubMed]
  • Schraufnagel DE, Leech JA, Schraufnagel MN, Pollak B. Short-course chemotherapy for mycobacteriosis kansasii? Can Med Assoc J. 1984 Jan 1;130(1):34–38. [PMC free article] [PubMed]
  • Hunter AM, Campbell IA, Jenkins PA, Smith AP. Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex. Thorax. 1981 May;36(5):326–329. [PMC free article] [PubMed]
  • Singh G. Treatment of septic arthritis due to Mycobacterium kansasii. Br Med J (Clin Res Ed) 1985 Mar 16;290(6471):857–857. [PMC free article] [PubMed]
  • Grange JM. Therapy of infections caused by 'atypical' mycobacteria. J Antimicrob Chemother. 1984 Apr;13(4):308–310. [PubMed]
  • Collins CH, Uttley AH. In-vitro susceptibility of mycobacteria to ciprofloxacin. J Antimicrob Chemother. 1985 Nov;16(5):575–580. [PubMed]
  • Dickinson JM, Mitchison DA. Activity of the combination of fludalanine and cycloserine against mycobacteria in vitro. Tubercle. 1985 Jun;66(2):109–115. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press